tiprankstipranks
Novartis AG (NVS)
:NVS
US Market
Holding NVS?
Track your performance easily

Novartis (NVS) Technical Analysis

3,619 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
6Neutral
15Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Novartis AG’s (NVS) Moving Averages Convergence Divergence (MACD) indicator is -0.76, suggesting Novartis AG is a Sell.
Novartis AG’s (NVS) 20-Day exponential moving average is 98.98, while Novartis AG’s (NVS) share price is $97.86, making it a Sell.
Novartis AG’s (NVS) 50-Day exponential moving average is 101.83, while Novartis AG’s (NVS) share price is $97.86, making it a Sell.

Novartis (NVS) Pivot Points

Jan 18, 2025, 02:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
97.92
98.41
98.74
99.24
99.56
100.06
100.39
Fibonacci
98.41
98.73
98.92
99.24
99.55
99.74
100.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novartis (NVS) Moving Averages

Jan 18, 2025, 02:55 AM
Period
Simple
Exponential
MA5
98.93Sell
98.69Sell
MA10
98.63Sell
98.68Sell
MA20
98.22Sell
98.98Sell
MA50
101.45Sell
101.83Sell
MA100
108.58Sell
104.79Sell
MA200
106.51Sell
104.10Sell
Novartis AG’s (NVS) 10-Day exponential moving average is 98.68, while Novartis AG’s (NVS) share price is $97.86, making it a Sell.
Novartis AG’s (NVS) 100-Day exponential moving average is 104.79, while Novartis AG’s (NVS) share price is $97.86, making it a Sell.
Novartis AG’s (NVS) stock price is $97.86 and Novartis AG’s (NVS) 50-day simple moving average is 101.45, creating a Sell signal.
Novartis AG’s (NVS) stock price is $97.86 and Novartis AG’s (NVS) 100-day simple moving average is 108.58, creating a Sell signal.
Novartis AG’s (NVS) stock price is $97.86 and Novartis AG’s (NVS) 200-day simple moving average is 106.51, creating a Sell signal.

Novartis (NVS) Technical Indicators

Jan 18, 2025, 02:55 AM
Name
Value
Implied Action
RSI (14)
40.17
Neutral
STOCH (9,6)
47.45
Neutral
STOCHRSI (14)
49.38
Neutral
MACD (12,26)
-0.76
Sell
ADX (14)
22.64
Neutral
Williams %R
-74.73
Buy
CCI (14)
10.55
Neutral
ATR (14)
1.26
-
Ultimate Oscillator
50.22
Neutral
ROC
-0.50
Sell
Novartis AG’s (NVS) Relative Strength Index (RSI) is 40.17, creating a Neutral signal.
Novartis AG’s (NVS) Trend Strength Indicator (ADX) is 22.64, creating a Neutral signal.
Novartis AG’s (NVS) Commodity Channel Index (CCI) is 10.55, creating a Neutral signal.
Novartis AG’s (NVS) Price Rate of Change (ROC) is -0.50, creating a Sell signal.

FAQ

Is NVS a Buy, Hold, or Sell?
Based on NVS’s technical indicators, NVS is a Strong Sell.
    What is NVS’s RSI (14)?
    NVS’s RSI (14) is 40.17, which suggests NVS is a Neutral.
      What is NVS’s MACD?
      NVS’s MACD is -0.76, which suggests NVS is a Sell.
        What is NVS’s 5-day moving average?
        NVS’s 5-day moving average is 98.93, which suggests NVS is a Sell.
          What is NVS’s 20-day moving average?
          NVS 20-day moving average is 98.22, which suggests NVS is a Sell.
            What is NVS’s 50-day moving average?
            NVS’s 50-day moving average is 101.45, which suggests NVS is a Sell.
              What is NVS’s 200-day moving average?
              NVS’s 200-day moving average is 106.51, which suggests NVS is a Sell.
                What is NVS’s Williams % R (14)?
                NVS’s Williams % R (14) is -74.73, which suggests NVS is a Buy.
                  What is NVS’s CCI (14)?
                  NVS’s CCI (14) is 10.55, which suggests NVS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis